BackThe Precision Peptide Company Overview

The Precision Peptide Company Current Assets

Track The Precision Peptide Company's current assets ($3.1M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$3.09M
↑ 44.54% YoYΔ $951244.00 vs prior year quarter

Peer trimmed avg / median

Loading

The Precision Peptide Company Current Assets History

Loading

The Precision Peptide Company vs. peers: Current Assets Comparison

Loading

The Precision Peptide Company Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

The Precision Peptide Company (PNGAF) FAQ

As of the most recent data (July 2026), PNGAF shows a current assets of $3.1M. That compares with $2.1M in the prior-year period — up 44.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PNGAF's current assets is now $3.1M (was $2.1M) — a 44.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether The Precision Peptide Company is outperforming or lagging.

Tracking PNGAF's current assets over time shows whether The Precision Peptide Company is scaling, shrinking, or reshaping that part of the business. The current reading is $3.1M That compares with $2.1M in the prior-year period — up 44.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has The Precision Peptide Company's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $3.1M) with ownership activity and broader fundamentals.

Questions & Answers